UnitedHealth Group Leaders See Cost Pressures Enduring

Jan. 16, 2025
The insurance giant and Optum parent is forecasting a 2025 medical care ratio roughly a point above last year’s 85.5 percent.

The volume-coding-payments tussle between hospital operators and insurance companies shows no signs of abating in 2025. And based on the fourth-quarter results and 2025 outlook of UnitedHealth Group Inc., it appears providers have the upper hand for now.

The leaders of Minnesota-based UnitedHealth Group, parent of UnitedHealthcare, said on Jan. 16 that the company’s medical care ratio, the share of premiums used to pay for medical expenses, finished 2024 at 85.5 percent, 40 basis points higher than analysts had expected. The company’s fourth-quarter MCR came in at more than 87 percent and CEO Andrew Witty and his team are forecasting it will be around 86.5 percent in 2025.

Speaking to analysts after reporting Q4 results—UnitedHealthcare’s headline numbers were $5.8 billion in net income on revenues of nearly $101 billion compared to $5.7 billion and $94.4 billion, respectively, in the same period of 2023—Witty and his lieutenants said a handful of factors contributed to the higher-than-expected medical costs. Among them were higher utilization, Medicare Advantage benefit changes and hundreds of millions in spending on the Change Healthcare cyberattack from nearly a year ago.

CFO John Rex also pointed to “an aggressive upshift in hospital coding intensity” as a headache United has had to handle for several quarters. Rex said that the “hospital coding intensity” accounted for about one-seventh of the 1.5 percentage point increase in United’s MCR from 2023. That dynamic, he added, stabilized in the fourth quarter and his team expects providers will continue to submit claims at a similar rate.

“We had noted back in the third quarter that was something that just moved faster in ’24 than we expected,” Rex said. “But in terms of the levels we’re seeing and how we anticipated that in our ’25 [forecasts], we feel very good about that.”

United hasn’t been alone in facing higher-than-expected medical costs as consumers have returned in force to the healthcare system since the COVID-19 pandemic’s peak. Last fall, CVS Health Corp. directors showed President and CEO Karen Lynch the door after poor results at the company’s Aetna insurance division and Elevance Health leaders cut their earnings forecast due to rising Medicaid cost trends.

On the other side of the coin, hospital operators have been bullish about utilization trends. Executives of HCA Healthcare Inc. and Tenet Health Corp. last year said they expect patients to continue to use their facilities at the pace at which they have been since roughly 2023. They and their peers also have been vocal about insurers’ attempts to limit or deny coverage—and at least one doesn’t see that changing soon.

Speaking at the 43rd JPMorgan Healthcare Conference Jan. 14, Ardent Health Partners Inc. CFO Alfred Lumsdaine also used the word “aggressive” to describe insurer practices, which he said took a big step up in 2024 as they sought to arrest rising cost trends. Lumsdaine said the Ardent team—which runs 30 hospitals and more than 200 other sites of care in six states—is counting on more of the same.

“We’re not seeing that get any worse in 2025 but I wouldn’t expect a significant improvement, either,” Lumsdaine said.

Among the other items of note from United’s Q4 report and conference call were:

Execs expect revenues at Optum Health, the company’s health services division, to grow to $117 billion this year from $105 billion in 2024. They also are forecasting the group will add about 650,000 patients to its value-based care programs, growing the scope of those to about 5.4 million.

Witty is committing United to passing along to customers 100 percent of the discounts its pharmacy benefit manager negotiates with drug companies. In 2024, that figure was 98 percent and Witty said a small number of customers have continued to opt for other models when it comes to their pharmaceutical benefits. Passing along the full rebates, Witty said, “will help make more transparent who is really responsible for drug pricing in this country—the drug companies themselves.”

Investors appeared far more focused on the higher medical costs Jan. 16: In late-afternoon trading, shares of United (Ticker: UNH) were changing hands around $513.50, down more than 4 percent from the prior session and at their lowest levels of the day. The drop wiped about $20 billion in market value from United, which is still worth more than $470 billion.

Sponsored Recommendations

Cloud Communications: Connecting Care at the Core

Cloud communications is the present, the recent past, and the future of collaborative healthcare.

The Ultimate HIPAA Security Guide for Cloud Communications

The healthcare industry is leading the charge in innovation, embracing cutting-edge technologies to enhance patient care and optimize operations. Forward-thinking organizations...

Improving Workplace Safety and Patient Care in Behavioral Health

In 2023, Vail Health enhanced safety in their behavioral health clinic, but the impact went beyond their expectations. Read their case study to see how prioritizing workplace ...

Transforming Hospital Capacity Through Smarter Patient Progression Strategies

Helping patients move seamlessly through every stage of their care, from admission to discharge, is critical to ensuring patient safety, improving outcomes, and optimizing capacity...